“Metamizole-Induced Agranulocytosis: Utilisation Trends, Pharmacovigilance Signals and Regulatory Risk-Minimisation in Switzerland”. 2026. Swiss Medical Weekly 156 (6): 5062. https://doi.org/10.57187/5062.